.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Midazolam hydrochloride - Generic Drug Details

« Back to Dashboard
Midazolam hydrochloride is the generic ingredient in four branded drugs marketed by Hospira Inc, Wockhardt, Sagent Strides, Apotex Inc, Apothecon, Intl Medication, Eurohlth Intl Sarl, Claris, Roche, Intl Medicated, Bedford, Gland Pharma Ltd, Fresenius Kabi Usa, HLR, Ben Venue, Hospira, Hi Tech Pharma, Sun Pharm Inds Ltd, Igi Labs Inc, Roxane, Paddock Llc, and Akorn Inc, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for midazolam hydrochloride. Twenty-three suppliers are listed for this compound.

Summary for Generic Name: midazolam hydrochloride

Tradenames:4
Patents:0
Applicants:22
NDAs:35
Drug Master File Entries: see list9
Suppliers / Packaging: see list23
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: midazolam hydrochloride

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075494-002Jun 30, 2000RXNo► subscribe► subscribe
Eurohlth Intl Sarl
MIDAZOLAM HYDROCHLORIDE
midazolam hydrochloride
INJECTABLE;INJECTION075243-002Jun 20, 2000RXNo► subscribe► subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 1987DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: midazolam hydrochloride

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
VERSED
midazolam hydrochloride
SYRUP;ORAL020942-001Oct 15, 19984,280,957*PED► subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-001Dec 20, 19854,280,957*PED► subscribe
Hlr
VERSED
midazolam hydrochloride
INJECTABLE;INJECTION018654-002May 26, 19874,280,957*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc